Work

An Orally Administered Multitarget Tyrosine Kinase Inhibitor, SU11248, Is a Novel Potent Inhibitor of Thyroid Oncogenic RET/Papillary Thyroid Cancer Kinases

Year: 2006

Type: article

Source: The Journal of Clinical Endocrinology & Metabolism

DOI: 10.1210/jc.2005-2845

Authors: Dong Wook Kim, Young Suk Jo, Hye Sook Jung, Hyo Kyun Chung, Jung Hun Song, Ki Cheol Park, Su Hyeon Park, Jung Hwan Hwang, So Young Rha, Gi Ryang Kweon, Su-Jae Lee, Ki-Won Jo, Minho Shong

Institutions: Chungnam National University, Seonam University, Korea Institute of Radiological and Medical Sciences, Korea Research Institute of Bioscience and Biotechnology

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2031614751

FWCI: 16.31

Cites: 30

Cited by: 282

Related to: 10